Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income (loss)	$ 279,804	$ 252,319	$ (185,344)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net impairments recognized in earnings	160	49,121	72,366
(Recovery of) provision for loan losses	(36,147)	(19,326)	146,478
Valuation allowance on loans held-for-sale		1,456	2,119
Gain on extinguishment of debt		(271,031)	(3,134)
Fair value adjustment on investment in CT Legacy Asset	(51,904)
Gain on deconsolidation of subsidiaries	(200,283)
Gain on sale of investments	(6,000)
Income from equity investments in unconsolidated subsidiaries	(1,781)	(3,649)	(3,608)
Distributions of income from unconsolidated subsidiaries	1,933	1,898	60
Loss on sale of discontinued operations, net of tax	271
Employee stock-based compensation	1,353	505	138
Incentive awards plan expense	2,232	3,054
Deferred directors' compensation	223	206	197
Distributions from CT Legacy Asset	9,581
Amortization of premiums/discounts on loans and securities and deferred interest on loans	(566)	(1,872)	(4,842)
Amortization of deferred gains and losses on settlement of swaps	(56)	(109)	(98)
Amortization of deferred financing costs and premiums/discounts on debt obligations	12,133	11,984	7,414
Deferred interest on senior credit facility			3,935
Loss on interest rate swaps not designated as cash flow hedges	2,772	6,336
Changes in assets and liabilities, net:
Accrued interest receivable	(3,560)	2,475	782
Deferred income taxes	1,268	(611)	1,374
Prepaid expenses and other assets	541	(1,813)	(74)
Accounts payable and accrued expenses	(5,206)	(2,059)	(1,326)
Net cash provided by operating activities	6,768	28,884	36,437
Cash flows from investing activities:
Proceeds from Investment Management Business Sale	21,424
Principal collections and proceeds from securities	56,544	94,407	55,864
Add-on fundings under existing loan commitments			(1,642)
Distributions from equity method investments		4,345
Principal collections of loans receivable	115,918	2,001,604	252,379
Proceeds from disposition of loans		5,750	25,298
Contributions to unconsolidated subsidiaries	(4,030)	(3,413)	(5,232)
Distributions from unconsolidated subsidiaries	1,006	3,697	2,200
Increase in restricted cash	(1,261)	(12,985)
Net cash provided by investing activities	189,601	2,093,405	328,867
Cash flows from financing activities:
Borrowings under repurchase obligations	123,977
Repayments under repurchase obligations	(58,464)	(314,215)	(78,025)
Repayments under senior credit facility		(22,932)	(5,000)
Repayment of junior subordinated notes		(4,640)
Borrowing under mezzanine loan		83,000
Repayments under mezzanine loan	(63,000)	(20,000)
Repayment of securitized debt obligations	(178,945)	(1,821,498)	(285,784)
Payment of financing expenses		(11,126)
Contributions from noncontrolling interests		125
Purchase of and distribution to noncontrolling interests	(16)	(144)
Purchase of secured notes		(405)
Vesting of restricted Class A common stock	(356)	(85)
Dividends paid on class A common stock	(48,960)
Proceeds from issuance of class A common stock	10,000
Net cash used in financing activities	(215,764)	(2,111,920)	(368,809)
Net (decrease) increase in cash and cash equivalents	(19,395)	10,369	(3,505)
Cash and cash equivalents at beginning of period	34,818	24,449	27,954
Cash and cash equivalents at end of period	$ 15,423	$ 34,818	$ 24,449